Evaluation of novel alginate foams as drug delivery systems in antimicrobial photodynamic therapy (aPDT) of infected wounds - An in vitro study: Studies on curcumin and curcuminoides XL

Journal of Pharmaceutical Sciences

Volumn 99, Issue 8, 2010, Pages 3499-3513

  Hegge, Anne Bee ^a   Andersen, T ^b   Melvik, J E ^b   Kristensen, S ^a   Tonnesen H H ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b FMC BioPolymer AS/NovaMatrix   (Norway)

Author keywords

Alginate; Content uniformity; Cyclodextrins; Formulation; Solubility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2 HYDROXYPROPYL GAMMA CYCLODEXTRIN; ALGINIC ACID; CURCUMIN; MACROGOL 400; SOLUBILIZER; UNCLASSIFIED DRUG; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; ANTIINFECTIVE AGENT; BETA CYCLODEXTRIN DERIVATIVE; DELAYED RELEASE FORMULATION; EXCIPIENT; GAMMA CYCLODEXTRIN DERIVATIVE; HYDROXYPROPYL-GAMMA-CYCLODEXTRIN;

ABSORPTION SPECTROSCOPY; ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; FOAM; HYDRATION; INSTRUMENT STERILIZATION; LIGHT EXPOSURE; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; WATER ABSORPTION; WOUND INFECTION; ABSORPTION; ANALOGS AND DERIVATIVES; CHEMISTRY; COLOR; DELAYED RELEASE FORMULATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; LIGHT; MEDICINAL CHEMISTRY; PHOTOCHEMOTHERAPY; PROCEDURES;

ABSORPTION; ALGINATES; ANTI-INFECTIVE AGENTS; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLOR; CURCUMIN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EXCIPIENTS; GAMMA-CYCLODEXTRINS; KINETICS; LIGHT; PHOTOCHEMOTHERAPY; STERILIZATION; WOUND INFECTION;

EID: 77955113460     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22119     Document Type: Article

References (55)

1. Maisch T. 2009. A new strategi to destroy antibiotic resistant microorganisms: Antimicrobial photodynamic treatment. Mini Rev Med Chem 9:974-983.
2. Hamblin MR, Hasan T. 2004. Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem Photobiol Sci 3:436-450.
3. Lauro FM, Pretto P, Covolo L, Jori G, Bertoloni G. 2002. Photoinactivation of bacterial strains involved in periodontal diseases sensitized by porphycene-polylysine conjugates. Photochem Photobiol Sci 1:468-470. (Pubitemid 41646498)
4. Jori G, Fabris C, Soncin M, Ferro S, Coppellotti O, Dei D, Fantetti L, Chiti G, Roneucci G. 2006. Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications. Lasers Surg Med 38:468-481.
5. Haukvik T, Bruzell E, Kristensen S, Tønnesen HH. 2009. Photokilling of bacteria by curcumin in different aqueous preparations. Studies on curcumin and curcuminoids XXXVII. Pharmazie 64:666-673.
6. Tsai T, Yang YT, Wang TH, Chien HF, Chen CT. 2009. Improved photodynamic inactivation of gram-positive bacteria using hematoporphyrin encapsulated in liposomes and micelles. Lasers Surg Med 41:316-322.
7. Dahl TA, McGowan WM, Shand MA, Srinivasan VS. 1989. Photokilling of bacteria by the natural dye curcumin. Arch Microbiol 151:183-185.
8. Dragicevic-Curic N, Gräfe S, Albrecht V, Fahr A. 2008. Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: A pilot study. J Photochem Photobiol B 91:41-50.
9. Kessel D. 2004. Delivery of photosensitizing agents. Adv Drug Deliv Rev 56:7-8.
10. Reddi E, Ceccon M, Valduga G, Jori G, Bommer JC, Elisei F, Latterini L, Mazzucato U. 2002. Photophysical properties and antibacterial activity of meso-substituted cationic porphyrins. Photochem Photobiol 75:462-470.
11. Varga O, Kubinyi M, Vidoczy T, Baranyai P, Bitter I, Kallay M. 2009. Methylene blue-calixarenesulfonate supramolecular complexes and aggregates in aqueous solutions. J Photochem Photobiol A Chem 207:167-172.
12. Matthews KH, Stevens HNE, Auffret AD. 2005. Lyophilised wafers as a drug delivery system for wound healing containing methylcellulose as a viscosity modifier. Int J Pharm 289:51-62.
13. Loughlin RG, Tunney MM, Donnelly RF, Murphy DJ, Jenkins M, McCarron PA. 2008. Modulation of gel formation and drugrelease characteristics of lidocaine-loaded poly(vinyl alcohol)-tetraborate hydrogel systems using scavenger polyol sugars. Eur J Pharm Biopharm 69:1135-1146.
14. Boateng JS, Matthews KH, Stevens HNE, Eccleston GM. 2008. Wound healing dressings and drug delivery systems: A review. J Pharm Sci 97:2892-2923.
15. Moe ST, Draget KI, Skjåk-Bræk G, Smidsrød O. 1995. Food polysaccharides and their applications. 1st edition. New York: Marcel Dekker.
16. Gaserod O, Andersen PO, Myrvold R. 2005. Gelled biopolymer based foam. In Corporation. F, editor, C08J 9/00 ed. United States patent application publication no. US 2005/0137272A1.
17. Smidsrød O, Draget KI. 1997. Alginate gelation technologies. In: Dickinson E, Bergenstahl B, editors. Food colloids - Proteins, lipids and polysaccharides. ed. 1. ed. Cambridge: The Royal Society of Chemistry. pp. 279-293.
18. Lai HL, Abu'Khalil A, Craig DQM. 2003. The preparation and characterisation of drug-loaded alginate and chitosan sponges. Int J Pharm 251:175-181.
19. Dai M, Zheng X, Xu X, Kong X, Li X, Guo G, Luo F, Zhao X, Wei Y, Qian Z. 2009. Chitosan-alginate sponge: Preparation and application in curcumin delivery for dermal wound healing in rat. J Biomed Biotechnol. art no. 595126, 8 pages
20. Qin YM. 2008. Alginate fibres: An overview of the production processes and applications in wound management. Polym Int 57:171-180.
21. Paul W, Sharma CP. 2004. Chitosan and alginate wound dressings: A short review. Trends Biomater Artif Organs 18: 18-23.
22. Pabon H. 1964. A synthesis of curcumin and related compounds. Recl Trav Chim Pays Bas 83:379-386.
23. Aggarwal BB, Bhatt ID, Ichikawa H, Ahn KS, Sethi G, Sandur SK, Sundaram C, Seeram N, Shishodia S. 2007. Curcuminbiological and medicinal properties. In: Ravindran PN, Nirmal Babu K, Sivaraman K, editors. Turmeric: The genius curcuma. ed. 1. New York: CRC Press. pp. 297-348.
24. Hatcher H, Planalp R, Cho J, Tortia FM, Torti SV. 2008. Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci 65:1631-1652.
25. Goel A, Jhurnai S, Aggarwal BB. 2008. Multi-target therapy by curcumin: How spicy is it? Mol Nutr Food Res 52:1-21.
26. Banerjee A, Kunwar A, Mishra B, Priyadarsini KI. 2008. Concentration dependent antioxidant/pro-oxidant activity of curcumin Studies from AAPH induced hemolysis of RBCs. Chem Biol Interact 174:134-139.
27. Strasser EM, Wessner B, Manhart N, Roth E. 2005. The relationship between the anti-inflammatory effects of curcumin and cellular glutathione content in myelomonocytic cells. Biochem Pharmacol 70:552-559.
28. Tønnesen HH, Karlsen J. 1985. Studies on curcumin and curcuminoids. V. Alkaline degradation of curcumin. Z Lebens Unters Forsch 180:132-134.
29. Tønnesen HH, Karlsen J, van Henegouwen GB. 1986. Studies on curcumin and curcuminoids. VIII. Photochemical stability of curcumin. Z Lebens Unters Forsch 183:116-1222.
30. Tomren MA, Masson M, Loftsson T, Tønnesen HH. 2007. Studies on curcumin and curcuminoids. XXXI. Symmetric and asymmetric curcuminoids: Stability, activity and complexation with cyclodextrin. Int J Pharm 338:27-34.
31. Tønnesen HH, Masson M, Loftsson T. 2002. Studies of curcumin and curcuminoides. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability. Int J Pharm 244:127-135. (Pubitemid 35245453)
32. Loftsson T, Brewster ME. 1996. Pharmaceutical application of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85:1017-1025.
33. Bautista-Sanchez A, Kasselouri A, Desroches MC, Blais J, Maillard P, de Oliveira DM, Tedesco AC, Prognon P, Delaire J. 2005. Photophysical properties of glucoconjugated chlorins and porphyrins and their associations with cyclodextrins. J Photochem Photobiol B 81:154-162.
34. Cosma P, Catucci L, Fini P, Dentuto PL, Agostiano A, Angelini N, Scolaro LM. 2006. Tetrakis(4-pyridyl)porphyrin supramolecular complexes with cyclodextrins in aqueous solution. Photochem Photobiol 82:563-569.
35. Masson M, Loftsson T, Masson G, Stefansson E. 1999. Cyclodextrins as permeation enhancers: Some theoretical evaluations and in vitro testing. J Control Release 59:107-118.
36. Hegge AB, Schuller RB, Kristiansen S, Tønnesen HH. 2008. In vitro release of curcumin from vehicles containing alginate and cyclodextrin. Studies of curcumin and curcuminoides XXXIII. Pharmazie 63:585-592.
37. Loftsson T, Jarvinen T. 1999. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev 36:59-79.
38. Loftsson T, Konradsdottir F, Masson M. 2006. Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes. Pharmazie 61:83-89. (Pubitemid 43297797)
39. Loftsson T, Vogensen SB, Brewster ME, Konradsdottir F. 2007. Effects of cyclodextrins on drug delivery thorugh biological membranes. J Pharm Sci 96:2532-2546.
40. Draget KI, Østgaard K, Smidsrød O. 1991. Homogeneous alginate gels: A technical approach. Carbohydr Polym 14:159-178.
41. Minolta. 1998. Precise color communication, color control from perception to instrumentation. ed. 1. Osaka: Minolta Co, Ltd.
42. European Pharmacopoeia 6.0. 2008. 5.1.1 Methods of preparation of sterile products. 60 European pharmacopoeia. 6th Edition 2008. pp. 525-527.
43. Tønnesen HH, Karlsen J. 1985. Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solutions. Z Lebens Unters Forsch 180:402-404.
44. Sue-Chu M, Kristensen S, Tønnesen HH. 2008. Influence of lagtime light exposure and color evaluation of riboflavin in the solid state. Pharmazie 63:545-546.
45. Hegge AB, Màsson M, Kristensen S, Tønnesen HH. 2009. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Pharmazie 64:382-389.
46. Kurien BT, Singh A, Matsumoto H, Scofield RH. 2007. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol 5:567-576.
47. Tønnesen HH. 2006. Solubility and stability of curcumin in solutions containing alginate and other viscosity modifying macromolecules: Studies of curcumin and curcuminoids. XXX. Pharmazie 61:696-700.
48. Bastos M, Afonso M, Cacote MHM, Ramos MJ. 1997. Interactions in the model system alfa-cyclodextrin-glycerol experimental and theoretical study. J Chem Soc Faraday Trans 93:2061-2067.
49. Priyadarsini KI. 2009. Photophysics, photochemistry and phtobiology of curcumin: Studies from organic solutions, biomimetics and living cells. J Photochem Photobiol C: Photochem Rev 10:81-95.
50. Tønnesen HH. 2004. Photostability of drugs and drug formulations. 2nd edition. Boca Raton: CRC Press.
51. Nardo L, Paderno R, Andreoni A, Masson M, Haukvik T, Tønnesen HH. 2008. Role of H-bond formation in the photoreactivity of curcumin. Spectroscopy 22:187-198. (Pubitemid 352039935)
52. Bortolus P, Monti S. 1996. Photochemistry in cyclodextrin cavities. In: Neckers DC, Volman DH, von Bünau G, editors. Advances in photochemistry. Vol. 21 edition. New York: John Wiley & Sons, Inc. pp. 1-133.
53. Frömming KH, Szejtli J. 1994. Cyclodextrins in pharmacy. Vol. 5 edition. Dordrecht: Kluwer Academic Publishers.
54. Tønnesen HH. 2004. Formulation approaches for improving solubility and its impact on drug photostability. Photostability of drugs and drug formulations. 2nd edition. Boca Roton, Florida: CRC Press LLC. pp. 351-371.
55. Nagasawa N, Mitomo H, Yoshii F, Kume T. 2000. Radiation-induced degradation of sodium alginate. Polym Degrad Stab 69:279-285.